Literature DB >> 19435792

SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis.

Thomas Henzi1, Walter-Vincent Blum, Martine Pfefferli, Tadeusz J Kawecki, Valerie Salicio, Beat Schwaller.   

Abstract

The calcium-binding protein calretinin has emerged as a useful marker for the identification of mesotheliomas of the epithelioid and mixed types, but its putative role in tumor development has not been addressed previously. Although exposure to asbestos fibers is considered the main cause of mesothelioma, undoubtedly, not all mesothelioma patients have a history of asbestos exposure. The question as to whether the SV40 virus is involved as a possible co-factor is still highly debated. Here we show that increased expression of SV40 early gene products in the mesothelial cell line MeT-5A induces the expression of calretinin and that elevated calretinin levels strongly correlate with increased resistance to asbestos cytotoxicity. Calretinin alone mediates a significant part of this protective effect because cells stably transfected with calretinin cDNA were clearly more resistant to the toxic effects of crocidolite than mock-transfected control cells. Down-regulation of calretinin by antisense methods restored the sensitivity to asbestos toxicity to a large degree. The protective effect observed in clones with higher calretinin expression levels could be eliminated by phosphatidylinositol 3-kinase (PI3K) inhibitors, implying an important role for the PI3K/AKT signaling (survival) pathway in mediating the protective effect. Up-regulation of calretinin, resulting from either asbestos exposure or SV40 oncoproteins, may be a common denominator that leads to increased resistance to asbestos cytotoxicity and thereby contributes to mesothelioma carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435792      PMCID: PMC2684196          DOI: 10.2353/ajpath.2009.080352

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  67 in total

1.  Phosphorylated extracellular signal-regulated kinases are significantly increased in malignant mesothelioma.

Authors:  Merivane de Melo; Margaret W Gerbase; Joseph Curran; Jean-Claude Pache
Journal:  J Histochem Cytochem       Date:  2006-03-03       Impact factor: 2.479

2.  Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection.

Authors:  Makoto Suzuki; Shinichi Toyooka; Narayan Shivapurkar; Hisayuki Shigematsu; Kuniharu Miyajima; Takao Takahashi; Victor Stastny; Andrea L Zern; Takehiko Fujisawa; Harvey I Pass; Michele Carbone; Adi F Gazdar
Journal:  Oncogene       Date:  2005-02-10       Impact factor: 9.867

3.  Evidence against a role for SV40 in human mesothelioma.

Authors:  James J Manfredi; Jianli Dong; Wen-jun Liu; Lois Resnick-Silverman; Rui Qiao; Philippe Chahinian; Marko Saric; Allen R Gibbs; James I Phillips; J Murray; Charles W Axten; Robert P Nolan; Stuart A Aaronson
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

4.  Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters.

Authors:  Barbara Kroczynska; Rochelle Cutrone; Maurizio Bocchetta; Haining Yang; Amira G Elmishad; Pamela Vacek; Maria Ramos-Nino; Brooke T Mossman; Harvey I Pass; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

Review 5.  SV40 and human tumours: myth, association or causality?

Authors:  Adi F Gazdar; Janet S Butel; Michele Carbone
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

6.  Association between the calcium-binding protein calretinin and cytoskeletal components in the human colon adenocarcinoma cell line WiDr.

Authors:  D Marilley; B Schwaller
Journal:  Exp Cell Res       Date:  2000-08-25       Impact factor: 3.905

7.  Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase.

Authors:  Maria E Ramos-Nino; Giovina Vianale; Tara Sabo-Attwood; Luciano Mutti; Camilo Porta; Nicholas Heintz; Brooke T Mossman
Journal:  Mol Cancer Ther       Date:  2005-05       Impact factor: 6.261

8.  Deficiency in parvalbumin, but not in calbindin D-28k upregulates mitochondrial volume and decreases smooth endoplasmic reticulum surface selectively in a peripheral, subplasmalemmal region in the soma of Purkinje cells.

Authors:  G Chen; P Racay; S Bichet; M R Celio; P Eggli; B Schwaller
Journal:  Neuroscience       Date:  2006-07-21       Impact factor: 3.590

9.  Simian virus 40-like DNA sequences in human pleural mesothelioma.

Authors:  M Carbone; H I Pass; P Rizzo; M Marinetti; M Di Muzio; D J Mew; A S Levine; A Procopio
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

10.  Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin.

Authors:  B Schwaller; P Buchwald; I Blümcke; M R Celio; W Hunziker
Journal:  Cell Calcium       Date:  1993-10       Impact factor: 6.817

View more
  17 in total

Review 1.  Simian virus 40 transformation, malignant mesothelioma and brain tumors.

Authors:  Fang Qi; Michele Carbone; Haining Yang; Giovanni Gaudino
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

Review 2.  What's the place of immunotherapy in malignant mesothelioma treatments?

Authors:  Marc Grégoire
Journal:  Cell Adh Migr       Date:  2010-01-30       Impact factor: 3.405

3.  Malignant mesothelioma: development to therapy.

Authors:  Joyce K Thompson; Catherine M Westbom; Arti Shukla
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

4.  Pathophysiology and biology of peritoneal carcinomatosis.

Authors:  Shigeki Kusamura; Dario Baratti; Nadia Zaffaroni; Raffaella Villa; Barbara Laterza; Maria Rosaria Balestra; Marcello Deraco
Journal:  World J Gastrointest Oncol       Date:  2010-01-15

5.  Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients.

Authors:  Irina Raiko; Ingrid Sander; Daniel G Weber; Monika Raulf-Heimsoth; Adrian Gillissen; Jens Kollmeier; Arnaud Scherpereel; Thomas Brüning; Georg Johnen
Journal:  BMC Cancer       Date:  2010-05-28       Impact factor: 4.430

6.  High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma.

Authors:  Elisa Mazzoni; Alfredo Corallini; Alfonso Cristaudo; Angelo Taronna; Gianfranco Tassi; Marco Manfrini; Manola Comar; Massimo Bovenzi; Roberto Guaschino; Francesca Vaniglia; Corrado Magnani; Ferruccio Casali; Giovanni Rezza; Giuseppe Barbanti-Brodano; Fernanda Martini; Mauro G Tognon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

Review 7.  Cytosolic Ca2+ Buffers Are Inherently Ca2+ Signal Modulators.

Authors:  Beat Schwaller
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-01-02       Impact factor: 10.005

8.  Data-driven information retrieval in heterogeneous collections of transcriptomics data links SIM2s to malignant pleural mesothelioma.

Authors:  José Caldas; Nils Gehlenborg; Eeva Kettunen; Ali Faisal; Mikko Rönty; Andrew G Nicholson; Sakari Knuutila; Alvis Brazma; Samuel Kaski
Journal:  Bioinformatics       Date:  2011-11-20       Impact factor: 6.937

9.  Overexpression or absence of calretinin in mouse primary mesothelial cells inversely affects proliferation and cell migration.

Authors:  Walter Blum; László Pecze; Emanuela Felley-Bosco; Beat Schwaller
Journal:  Respir Res       Date:  2015-12-22

Review 10.  Calretinin: from a "simple" Ca(2+) buffer to a multifunctional protein implicated in many biological processes.

Authors:  Beat Schwaller
Journal:  Front Neuroanat       Date:  2014-02-05       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.